Line 11: |
Line 11: |
| '''CLL Tables''' - A list of clinically significant and/or recurrent CNAs and CN-LOH with potential or strong diagnostic, prognostic and treatment implications in CLL. Table derived from Chun et al., 2018 [<nowiki>PMID 30554732</nowiki>] with permission from Cancer Genetics. See [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH]]. | | '''CLL Tables''' - A list of clinically significant and/or recurrent CNAs and CN-LOH with potential or strong diagnostic, prognostic and treatment implications in CLL. Table derived from Chun et al., 2018 [<nowiki>PMID 30554732</nowiki>] with permission from Cancer Genetics. See [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH]]. |
| | | |
− | '''Plasma cell NeoplasmsTables''' - A comprehensive list of CNAs and CN-LOH associated with diagnostic, prognostic and treatment implications in plasma cell neoplasms. Table derived from Pugh et al., 2018 [<nowiki>PMID 30393007</nowiki>] with permission from Cancer Genetics. ''See [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations]].'' | + | '''Plasma cell NeoplasmsTables''' - A comprehensive list of CNAs and CN-LOH associated with diagnostic, prognostic and treatment implications in plasma cell neoplasms. Table derived from Pugh et al., 2018 [<nowiki>PMID 30393007</nowiki>] with permission from Cancer Genetics. ''See [[HAEM4:Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations]].'' |
| | | |
| Put your graphics here | | Put your graphics here |
Line 21: |
Line 21: |
| ==WHO Classification Pages (Includes Links to Content)== | | ==WHO Classification Pages (Includes Links to Content)== |
| | | |
− | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | + | *[[HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma]] |
| | | |
− | - [[Monoclonal B-cell Lymphocytosis]] | + | - [[HAEM5:Monoclonal B-cell lymphocytosis]] |
| | | |
− | *[[B-cell Prolymphocytic Leukemia]] | + | *[[HAEM4:B-cell Prolymphocytic Leukemia]] |
| | | |
− | *[[Splenic Marginal Zone Lymphoma]] | + | *[[HAEM5:Splenic marginal zone lymphoma]] |
| | | |
− | *[[Hairy Cell Leukemia]] | + | *[[HAEM5:Hairy cell leukaemia]] |
| | | |
− | *[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] | + | *[[HAEM4:Splenic B-cell Lymphoma/Leukemia, Unclassifiable]] |
| | | |
− | - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]] | + | - [[HAEM5:Splenic diffuse red pulp small B-cell lymphoma]] |
− | - [[Hairy Cell Leukemia Variant]] | + | - [[HAEM5:Hairy cell leukaemia Variant]] |
| | | |
− | *[[Lymphoplasmacytic Lymphoma]] | + | *[[HAEM5:Lymphoplasmacytic lymphoma]] |
| | | |
− | - [[Waldenstrom Macroglobulinemia]] | + | - [[HAEM5:Lymphoplasmacytic lymphoma]] |
| | | |
− | *[[IgM Monoclonal Gammopathy of Undetermined Significance]] | + | *[[HAEM5:IgM monoclonal gammopathy of undetermined significance]] |
| | | |
− | *[[Heavy Chain Diseases]] | + | *[[HAEM4:Heavy Chain Diseases]] |
| | | |
− | - [[Mu Heavy Chain Disease]] | + | - [[HAEM5:Mu heavy chain disease]] |
− | - [[Gamma Heavy Chain Disease]] | + | - [[HAEM5:Gamma heavy chain disease]] |
− | - [[Alpha Heavy Chain Disease]] | + | - [[HAEM5:Alpha heavy chain disease]] |
| | | |
− | *[[Plasma Cell Neoplasms]] | + | *[[HAEM4:Plasma Cell Neoplasms]] |
| | | |
− | - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]] | + | - [[HAEM5:Non-IgM monoclonal gammopathy of undetermined significance]] |
− | - [[Plasma Cell Myeloma]] | + | - [[HAEM5:Plasma cell myeloma / multiple myeloma]] |
− | - [[Plasma Cell Myeloma Variants]] | + | - [[HAEM5:Plasma cell myeloma / multiple myeloma Variants]] |
− | - [[Plasmacytoma]] | + | - [[HAEM5:Plasmacytoma]] |
− | - [[Monoclonal Immunoglobulin Deposition Diseases]] | + | - [[HAEM4:Monoclonal Immunoglobulin Deposition Diseases]] |
− | - [[Primary Amyloidosis]] | + | - [[HAEM5:Immunoglobulin-related (AL) amyloidosis]] |
− | - [[Light Chain and Heavy Chain Deposition Disease]] | + | - [[HAEM5:Monoclonal immunoglobulin deposition disease]] |
− | - [[Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] | + | - [[HAEM4:Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]] |
− | - [[POEMS Syndrome]] | + | - [[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome]] |
− | - [[TEMPI Syndrome]] | + | - [[HAEM5:Plasma cell neoplasms with associated paraneoplastic syndrome]] |
| | | |
− | *[[Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]] | + | *[[HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]] |
| | | |
− | *[[Nodal Marginal Zone Lymphoma]] | + | *[[HAEM5:Nodal marginal zone lymphoma]] |
| | | |
− | - [[Paediatric Nodal Marginal Zone Lymphoma]] | + | - [[HAEM5:Paediatric nodal marginal zone lymphoma]] |
| | | |
− | *[[Follicular Lymphoma]] | + | *[[HAEM5:Follicular lymphoma]] |
| | | |
− | - [[Testicular Follicular Lymphoma]] | + | - [[HAEM5:Follicular lymphoma]] |
− | - [[In Situ Follicular Neoplasia]] | + | - [[HAEM5:In situ follicular B-cell neoplasm]] |
− | - [[Duodenal-Type Follicular Lymphoma]] | + | - [[HAEM5:Duodenal-type follicular lymphoma]] |
| | | |
− | *[[Paediatric-Type Follicular Lymphoma]] | + | *[[HAEM5:Paediatric-type follicular lymphoma]] |
| | | |
− | *[[Large B-cell Lymphoma with IRF4 Rearrangement]] | + | *[[HAEM5:Large B-cell lymphoma with IRF4 rearrangement]] |
| | | |
− | *[[Primary Cutaneous Follicle Centre Lymphoma]] | + | *[[HAEM5:Primary cutaneous follicle centre lymphoma]] |
| | | |
− | *[[Mantle Cell Lymphoma]] | + | *[[HAEM5:Mantle cell lymphoma]] |
| | | |
− | - [[Leukemic Non-Nodal Mantle Cell Lymphoma]] | + | - [[HAEM5:Leukaemic non-nodal mantle cell lymphoma]] |
− | - [[In Situ Mantle Cell Neoplasia]] | + | - [[HAEM5:In situ mantle cell neoplasm]] |
| | | |
− | *[[Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] | + | *[[HAEM4:Diffuse Large B-cell Lymphoma, Not Otherwise Specified]] |
| | | |
− | *[[T-cell/Histiocyte-Rich Large B-cell Lymphoma]] | + | *[[HAEM5:T-cell/histiocyte-rich large B-cell lymphoma]] |
| | | |
− | *[[Primary Diffuse Large B-cell Lymphoma of the CNS]] | + | *[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites]] |
| | | |
− | *[[Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type]] | + | *[[HAEM5:Primary cutaneous diffuse large B-cell lymphoma, leg type]] |
| | | |
− | *[[EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | *[[HAEM5:EBV-positive diffuse large B-cell lymphoma]] |
| | | |
− | *[[EBV-Positive Mucocutaneous Ulcer]] | + | *[[HAEM5:EBV-positive mucocutaneous ulcer]] |
| | | |
− | *[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]] | + | *[[HAEM5:Diffuse large B-cell lymphoma associated with chronic inflammation]] |
| | | |
− | - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]] | + | - [[HAEM5:Fibrin-associated large B-cell lymphoma]] |
| | | |
− | *[[Lymphomatoid Granulomatosis]] | + | *[[HAEM5:Lymphomatoid granulomatosis]] |
| | | |
− | *[[Primary Mediastinal (Thymic) Large B-cell Lymphoma]] | + | *[[HAEM5:Primary mediastinal large B-cell lymphoma]] |
| | | |
− | *[[Intravascular Large B-cell Lymphoma]] | + | *[[HAEM5:Intravascular large B-cell lymphoma]] |
| | | |
− | *[[ALK-Positive Large B-cell Lymphoma]] | + | *[[HAEM5:ALK-positive large B-cell lymphoma]] |
| | | |
− | *[[Plasmablastic Lymphoma]] | + | *[[HAEM5:Plasmablastic lymphoma]] |
| | | |
− | *[[Primary Effusion Lymphoma]] | + | *[[HAEM5:Primary effusion lymphoma]] |
| | | |
− | *[[HHV8-Associated Lymphoproliferative Disorders]] | + | *[[HAEM4:HHV8-Associated Lymphoproliferative Disorders]] |
| | | |
− | - [[Multicentric Castleman Disease]] | + | - [[HAEM5:KSHV/HHV8-associated multicentric Castleman disease]] |
− | - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | - [[HAEM5:KSHV/HHV8-positive diffuse large B-cell lymphoma]] |
− | - [[HHV8-Positive Germinotropic Lymphoproliferative Disorder]] | + | - [[HAEM5:KSHV/HHV8-positive germinotropic lymphoproliferative disorder]] |
| | | |
− | *[[Burkitt Lymphoma]] | + | *[[HAEM5:Burkitt lymphoma]] |
| | | |
− | *[[Burkitt-Like Lymphoma with 11q Aberration]] | + | *[[HAEM5:High grade B-cell lymphoma with 11q aberrations]] |
| | | |
− | *[[High-Grade B-cell Lymphoma]] | + | *[[HAEM4:High-Grade B-cell Lymphoma]] |
| | | |
− | - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] | + | - [[HAEM4:High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]] |
− | - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] | + | - [[HAEM4:High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]] |
| | | |
− | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | + | *[[HAEM5:Mediastinal grey zone lymphoma]] |
| | | |
| ==Other Related Pages (Includes Links to Content)== | | ==Other Related Pages (Includes Links to Content)== |